In a report published on Friday, BMO Capital Markets analyst Joanne K. Wuensch raised the price target on Wright Medical Group WMGI to $31 from $26 and reiterated an Outperform rating.
In the report, BMO Capital Markets noted, "On its own, without Augment (which is not in our model), we believe WMGI can trade at 4.0x-4.5x 2014E EV/revenue, or a price target range of $29-$32. Augment could add another $4-$5 to our price target, based on a DCF basis analysis. Thus, we are increasing our PT to $31 from $26".
Wright Medical Group closed on Friday at $27.20.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in